Choose Providence Business First as a preferred news source to see more of our reporting on Google. The Galway-based company ...

After cutting down its pipeline just a few months ago, OSE Immunotherapeutics is at it again, this time reorganizing as Boehringer Ingelheim walks away from the biotech’s metabolic ...

Investing Platform founder Adnan Tanveer reports strong deal flow at Emergence 2026, with opportunities spanning ...

Lacks’ cervical cancer cells, called “HeLa” after the first two letters of her first and last name, are immortal, continuing to divide when most cells would die. This ability to survive through ...

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.

Choose South Florida Business Journal as a preferred news source to see more of our reporting on Google. It said the decision ...

Days after FDA Commissioner Marty Makary appeared to malign uniQure’s AMT-130 in an interview with CNBC, the agency confirmed ...

Technical.ly’s annual list is expanding beyond just Baltimore for the first time, highlighting companies making an outsized impact in every corner of the state.

Meanwhile, 93-year-old vaccine legend Stanley Plotkin is watching vaccination rates slip and calling the anti-vaccine turn inside government what he thinks it is: “stupid” and “immoral.” Also, a ...

I have been involved in launching medtech products across nearly 30 markets. These are the lessons that only became clear once products entered the real world.

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.